Supplier News Breaks Archives
Novo Nordisk's new U.S. headquarters makes debut
April 19th, 2013
PLAINSBORO, N.J. – Novo Nordisk has unveiled its new U.S. headquarters, a 731,000-square-foot facility in Plainsboro, N.J.
The Denmark-based health care company said Friday that the world-class building is the result of a $225 million redevelopment project, which leveraged an existing structure and sustainable materials to limit environmental impact.
"Becoming a leading health care company requires not only the best people in the field, but a work environment that fosters collaboration," said Jurek Gruhn, president of Novo Nordisk's U.S. business. "Our new home provides our employees with the physical space and resources to fuel our continued commitment to provide the best possible solutions for diabetes patients in the United States."
The redeveloped building was designed to promote innovation, teamwork and employee wellness, Novo Nordisk noted. Features include a state-of-the-art cafeteria, a one-mile scenic walking path, and special quiet focus areas for employees.
On hand for the HQ building's debut were state and local officials, including New Jersey Lieutenant Gov. Kim Guadagno, U.S. Sen. Bob Menendez (D., N.J.), U.S. Rep. Rush Holt (D., N.J.), State Senate President Steve Sweeney, and Plainsboro Town Mayor Peter Cantu, along with local organizations and community partners.
"The completion of this project and launch of Novo Nordisk's new headquarters is a milestone in the long and proud history of the life sciences industry here in New Jersey," stated Lt. Governor Guadagno. "We are gratified that this great global company has reaffirmed its belief that our state is an ideal location for a fast-growing, research-based business to plant its flag. The impact of Novo Nordisk's investment will continue well into the future as additional jobs are created for our skilled New Jersey workforce."
Novo Nordisk said the LEED Silver certified campus is fully powered by renewable energy from wind, solar, and hydro sources, a feature that is expected to lead to a 30% reduction in energy costs. The company added that its initial plans are to occupy 75% of the building's capacity, leaving room for future expansion.
"The country's diabetes epidemic is a serious and growing threat in the state and in our communities," commented Menendez. "Novo Nordisk's new building and the work being done here represents hope for people with diabetes and those caring for loved ones with diabetes."